Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

GeneTex Launches PD-L1 Antibody Comprehensively Validated by MS Validated Antibodies GmbH for Immunohistochemistry: https://www.irw-press.at/prcom/images/messages/2023/70848/GeneTexGlobal_EN_PRcom.001.jpeg
GeneTex Launches PD-L1 Antibody Comprehensively Validated by MS Validated Antibodies GmbH for Immunohistochemistry

IRVINE, CA / ACCESSWIRE / June 6, 2023 / GeneTex, a multinational antibody manufacturing company, is leveraging its recombinant monoclonal antibody production platform to produce

GeneTex lanciert PD-L1-Antikörper, der von MS Validated Antibodies GmbH für Immunhistochemie umfassend validiert wurde: https://www.irw-press.at/prcom/images/messages/2023/70848/GeneTexGlobal_DE_PRcom.001.jpeg
GeneTex lanciert PD-L1-Antikörper, der von MS Validated Antibodies GmbH für Immunhistochemie umfassend validiert wurde

Irvine, CA / Accesswire / 6. Juni 2023 / GeneTex, ein multinationales Unternehmen zur Antikörperherstellung, nutzt seine Produktionsplattform für rekombinante monoklonale Antikörper, um

Is Verizon’s 7% Yield Too Good To Pass Up?: https://www.marketbeat.com/logos/articles/med_20230605083306_chart-vz-652023.png
Is Verizon’s 7% Yield Too Good To Pass Up?

Shares of Verizon (NYSE: VZ) have been shedding value for more than 2 years, and that trend could continue, but there are a growing number of signs that suggest the bottom is in. Among them is the

Risk-On In Small-Caps After iShares Russell 2000 ETF Breaks Out: https://www.marketbeat.com/logos/articles/med_20230604121708_iwm-chart.jpg
Risk-On In Small-Caps After iShares Russell 2000 ETF Breaks Out

The iShares Russell 2000 ETF (NYSE: IWM) has displayed relative weakness and lagged the overall market over the previous year. However, it notably broke that trend last week and finally showed

Will Nvidia Be the Lifeline Intel Desperately Needs?: https://www.marketbeat.com/logos/articles/20230602120259_image.png
Will Nvidia Be the Lifeline Intel Desperately Needs?

Nvidia Co. (NASDAQ: NVDA) CEO Jensen Huang sparked market whispers this week, hinting at enlisting Intel Co. (NASDAQ: INTC) to produce chips. Huang told reporters that Nvidia is "open to

What Should Investors Make of These 3 Dividend Cuts?: https://www.marketbeat.com/logos/articles/med_20230602113015_what-should-investors-make-of-these-3-dividend-cut.jpg
What Should Investors Make of These 3 Dividend Cuts?

Regarding steak marinades and financial debt, reductions are good — but not so much with stock dividends.

A board of director's decision to employ dividend cuts is usually motivated by a need to

Symbotic AI Robots Disrupt Warehouse Industry, Stock Price Soars: https://www.marketbeat.com/logos/articles/med_20230602063706_symbotic-ai-robots-disrupt-warehouse-industry-stoc.jpg
Symbotic AI Robots Disrupt Warehouse Industry, Stock Price Soars

Robots choosing your food? Say it ain’t so!

It may not be quite that futuristic (or dystopian, depending on your viewpoint), but Symbotic Inc. (NASDAQ: SYM) posted gains for six months in a row

Opera Stock: The Fast-Rising Star of AI-Driven Web Experiences: https://www.marketbeat.com/logos/articles/med_20230601114315_opera-the-fast-rising-star-of-ai-driven-web-experi.jpg
Opera Stock: The Fast-Rising Star of AI-Driven Web Experiences

It has become clear that AI mania is the investment theme du jour. The fortunes of semiconductor stocks surged in recent months, fueled by the AI boom and the increasing demand for advanced

Mobileye Global Shows Resilience, Igniting Investor Confidence: https://www.marketbeat.com/logos/articles/med_20230601073056_mobileye-global-shows-resilience-igniting-investor.jpg
Mobileye Global Shows Resilience, Igniting Investor Confidence

Mobileye Global Inc. (NASDAQ: MBLY) is showing signs life, reminiscent of the iconic scene from "Monty Python's Life of Brian" where a character declares, "I’m not dead yet!"

After a selloff

Is CXApp Inc.an AI Contender or Pretender?: https://www.marketbeat.com/logos/articles/med_20230528141547_chart0cxai.jpg
Is CXApp Inc.an AI Contender or Pretender?

CXApp Inc. (NASDAQ: CXAI) shares have been caught up in the artificial intelligence (AI) mania. On no news, its shares spiked to $21 on April 23, 2023, and have been melting since. The AI bug has

UiPath Stock Has Short-Term Pain for Long-Term AI Gain: https://www.marketbeat.com/logos/articles/med_20230528142229_chart-path2.jpg
UiPath Stock Has Short-Term Pain for Long-Term AI Gain

UiPath Inc. (NASDAQ: PATH) shares took an initial dive on its fiscal Q1 earnings release. The culprit was lowered fiscal Q2 2024 revenue guidance that spooked investors. However, the company

Palantir: The "Sleeper" Play on the AI Revolution: https://www.marketbeat.com/logos/articles/med_20230530110724_palantir-the-sleeper-play-on-the-ai-revolution.jpg
Palantir: The "Sleeper" Play on the AI Revolution

Nvidia CEO Jensen Huang calls ChatGPT's November 2022 release the AI industry's "iPhone moment," triggering an arms race among tech firms, big and small. Microsoft quickly bought half of OpenAI

AI Chip Stock Showdown: The Biggest Winners and Losers: https://www.marketbeat.com/logos/articles/med_20230530104818_ai-chip-stock-showdown-the-biggest-winners-and-los.jpg
AI Chip Stock Showdown: The Biggest Winners and Losers

With the AI boom in full swing, many investors are looking to chip makers as the companies that will proverbially sell picks and shovels in the AI gold rush. The thinking goes that the companies

Iovance Biotherapeutics Spikes on Melanoma BLA FDA Application: https://www.marketbeat.com/logos/articles/med_20230530101326_chart-iova.jpg
Iovance Biotherapeutics Spikes on Melanoma BLA FDA Application

Iovance Biotherapeutics Inc. (NASDAQ: IOVA) shares spiked over 20% on its advanced-stage melanoma treatment application to the U.S. Food and Drug Administration (FDA). The company submitted, and

Arista Networks Soars As Investors Spot Opportunity After Selloff: https://www.marketbeat.com/logos/articles/med_20230529192544_arista-networks-soars-as-investors-spot-opportunit.jpg
Arista Networks Soars As Investors Spot Opportunity After Selloff

Sometimes when looking at a stock’s chart, you can actually when investors disagree with a selloff. That’s the case with Arista Networks Inc. (NYSE: ANET), which sold off hard after its

Pfizer Has the Prescription for Higher Share Prices: https://www.marketbeat.com/logos/articles/med_20230524125944_pfizer-has-the-prescription-for-higher-share-price.jpg
Pfizer Has the Prescription for Higher Share Prices

Pfizer Inc. (NYSE: PFE) released the results of a peer review study that sent shares up more than 5%. The study evaluated the company’s GLP-1 receptor agonist, danuglipron. The compound aimed to

Doximity is an Overlooked Medical Ecosystem AI Play: https://www.marketbeat.com/logos/articles/med_20230521161256_chart-docs.jpg
Doximity is an Overlooked Medical Ecosystem AI Play

Doximity Inc. (NASDAQ: DOCS) is a digital professional social network platform for medical practitioners. It’s a medical community networking platform like a Microsoft Co. (NASDAQ: MSFT) owned

Can IonQ Be the Leader in Quantum Computing as a Service?: https://www.marketbeat.com/logos/articles/med_20230521162346_chart-ionq.jpg
Can IonQ Be the Leader in Quantum Computing as a Service?

Quantum computing has become a reality as more applications materialize. The viral growth of artificial intelligence (AI) applications driven by the AI battle between Alphabet Inc. (NASDAQ: GOOGL)

2 Tech Stocks With Upgrades and Positive Outlook: https://www.marketbeat.com/logos/articles/med_20230522104438_chart-sym-5222023.png
2 Tech Stocks With Upgrades and Positive Outlook

Symbotic (NASDAQ: SYM) and Global-e Online (NASDAQ: GLBE) are members of the 2022 class of IPOs. The 1st came to market as a reverse merger, while the other went the traditional IPO route with

C3.ai Executes a Rope-a-Dope Attack on Sleeping Bears: https://www.marketbeat.com/logos/articles/med_20230521160925_charty-ai.jpg
C3.ai Executes a Rope-a-Dope Attack on Sleeping Bears

Enterprise artificial intelligence (AI) software provider C3.ai Inc. (NASDAQ: AI) surprised investors by raising its fiscal Q4 2023 earnings two weeks before its release. It sent shares surging

Don’t Get Burned By The AI Boom: https://www.marketbeat.com/logos/articles/med_20230522083221_chart-amzn-msft-5222023.png
Don’t Get Burned By The AI Boom

AI is happening. It’s about to change the world and will cause a boom in productivity unlike any we’ve seen. The shift to AI will also cause a boom in the stock market, and investors should be

The ‘Other’ Coke Stock Quietly Hits a Record High: https://www.marketbeat.com/logos/articles/med_20230522072029_the-other-coke-stock-quietly-hits-a-record-high.jpg
The ‘Other’ Coke Stock Quietly Hits a Record High

Coca-Cola Europacific Partners plc (NYSE: CCEP) is one of a six-pack of ways to invest in classic beverage maker Coke — and a darn good one at that. 

Over the last 12 months, the world’s largest

What's Behind The Recent Meteoric Rise Of Tingo Group: https://www.marketbeat.com/logos/articles/20230521083322_tingo.png
What's Behind The Recent Meteoric Rise Of Tingo Group

Tingo Group NASD: TIO is a global fintech and agri-tech company with operations spanning multiple continents. The company operates in Africa, Southeast Asia, and the Middle East. Tingo’s wholly

Analyst Flags Concerns About P&G Growth Despite Earnings Beat: https://www.marketbeat.com/logos/articles/med_20230521192353_analyst-flags-concerns-about-pg-growth-despite-ear.jpg
Analyst Flags Concerns About P&G Growth Despite Earnings Beat

If you look around your house you’re almost certain to find Procter & Gamble Co. (NYSE: PG) brands somewhere in the kitchen or bathroom.

While the company’s products are well-known and

Is Pfizer's Seagen Deal In Jeopardy Amid Antitrust Scrutiny?: https://www.marketbeat.com/logos/articles/med_20230518141428_is-pfizers-seagen-deal-in-jeopardy-amid-antitrust.jpg
Is Pfizer's Seagen Deal In Jeopardy Amid Antitrust Scrutiny?

Pfizer Inc. (NYSE: PFE) continued its downward trajectory on May 17, following news that the Federal Trade Commission is seeking to block Amgen Inc.’s (NASDAQ: AMGN) planned acquisition of Horizon